James Mish

Ashland LLC engages in the manufacture and distribution of specialty chemical solutions. It operates through the following segment: Specialty Ingredients, Composites, and Intermediates and Solvents. The Specialty Ingredients segment offers cellulose ethers, vinyl pyrrolidones, and bifunctional. The Composites segment includes unsaturated polyester resins, vinyl ester resins, and gelcoats. The Intermediates and Solvents segment produces butanediol (BDO) and related derivatives, including tetrahydrofuran and n-methylpyrrolidone. The company was founded by Paul G. Blazer in 1924 and is headquartered in Covington, KY.

Exactus, Inc. produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The firm's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company was founded in 2008 and is headquartered in Delray Beach, FL.

Noramco, Inc. manufactures and supplies pharmaceutical products. Its products include controlled substances, medical devices, and active ingredients for various pharmaceutical companies. The company was founded in 1979 and is headquartered in Athens, GA.

Purisys LLC is a leading supplier of API CDMO services and pharmaceutical reference standards. The company is based in Athens, GA and has a 17,000-square-foot manufacturing facility and innovation center staffed by experienced professionals in complex high-barrier custom synthetic chemistry. Purisys specializes in controlled substance APIs and has 6 DEA registrations encompassing 48 drug codes. The company also stocks a catalog of more than 250 commercial reference standards that support pharmaceutical drug product development and manufacturing. In addition, Purisys is an ingredient and solutions provider to pharmaceutical and consumer products companies exploring CBD and other cannabinoid-based ingredients. The company maintains the broadest cannabinoid portfolio on the market, with experience producing commercial quantities of ingredients for over 10 years. James A Mish has been the CEO of the company since 2019.

Psilotec Health Solutions, Inc. is a Canadian biopharmaceutical company. The private company is based in Calgary, Canada. The CEO of the company is Peter Silverstone.